Krka, d. d.'s latest marketcap:
As of 08/13/2025, Krka, d. d.'s market capitalization has reached $7.1 B. According to our data, Krka, d. d. is the 2593th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 7.1 B |
| Revenue (ttm) | 2.3 B |
| Net Income (ttm) | 444.99 M |
| Shares Out | 30.54 M |
| EPS (ttm) | 14.51 |
| Forward PE | 15.83 |
| Ex-Dividend Date | 07/22/2025 |
| Earnings Date | 07/24/2025 |
Krka, d. d.'s yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/13/2025 | €6.08 B | $7.1 B | 41.84% | 2593 |
| 12/30/2024 | €4.27 B | $4.42 B | 25.64% | 3281 |
| 12/29/2023 | €3.4 B | $3.75 B | 19.08% | 3603 |
| 12/30/2022 | €2.86 B | $3.06 B | -22.28% | 3973 |
| 12/30/2021 | €3.68 B | $4.18 B | 28.44% | 3699 |
| 12/30/2020 | €2.86 B | $3.5 B | 23.38% | 3738 |
| 12/30/2019 | €2.32 B | $2.6 B | 25.52% | 3861 |
| 12/28/2018 | €1.85 B | $2.12 B | -0.05% | 3861 |
| 12/29/2017 | €1.85 B | $2.22 B | 7.93% | 4270 |
| 12/30/2016 | €1.71 B | $1.8 B | -19.21% | 4267 |
Company Profile
About Krka, d. d.
Krka, d. d. is a leading generic pharmaceutical company specializing in the development, production, and distribution of prescription pharmaceuticals, over-the-counter (OTC) products, and animal health solutions. Headquartered in Novo Mesto, Slovenia, the company operates across Europe and internationally.
Core Business Areas
- Prescription Pharmaceuticals: Offers treatments for cardiovascular diseases, alimentary tract and metabolism disorders, central nervous system conditions, infections, oncology, and more.
- Non-Prescription Products: Includes oral and pharyngeal care, cough and cold remedies, analgesics, nasal products, vitamins, digestive aids, and general healthcare items.
- Animal Health Products: Provides antimicrobials, antiparasitics, disinfectants, vitamins, minerals, and analgesics for veterinary use.
Additional Services
Beyond pharmaceuticals, Krka also offers health resort and tourist services, enhancing its commitment to holistic well-being.
Founded in 1954, Krka has grown into a trusted name in the pharmaceutical industry, delivering high-quality healthcare solutions worldwide.
Frequently Asked Questions
-
What is Krka, d. d.'s (LJSE-KRKG) current market cap?As of 08/13/2025, Krka, d. d. (including the parent company, if applicable) has an estimated market capitalization of $7.1 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Krka, d. d. (LJSE-KRKG) rank globally by market cap?Krka, d. d. global market capitalization ranking is approximately 2593 as of 08/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.